Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1 10Phase 1/2 3

Status

Terminated 3Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1

Conditions

Sarcoma 1Neurofibrosarcoma 1Lung Cancer - Malignant Pleural Mesothelioma 1Leukemia, Myeloid, Acute 1Leukemia 1

Interventions

Cyclophosphamide 142Gemcitabine 129Paclitaxel 125Radiotherapy 119Carboplatin 112Cisplatin 111pembrolizumab 110Nivolumab 106Docetaxel 90Rituximab 86Lenalidomide 77Dexamethasone 76Cytarabine 69Bevacizumab 64Fluorouracil 63Etoposide 63Oxaliplatin 62Filgrastim 59Peripheral Blood Stem Cell Transplantation 58Everolimus 58Capecitabine 58fludarabine phosphate 57Doxorubicin 56Temozolomide 55Prednisone 54Irinotecan 53Cetuximab 50fludarabine 48Ipilimumab 48Erlotinib Hydrochloride 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × STA 9090 × Clear all
NCT01590160 2019-11-13

MESO-02

University College, London

Phase 1/2 Completed
27 enrolled
Other solid neoplasmThoracic

Lung Cancer - Malignant Pleural Mesothelioma

NCT02008877 2019-05-15

SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)

Sarcoma Alliance for Research through Collaboration

Phase 1/2 Completed
20 enrolled 20 charts
Sarcoma

Sarcoma, Neurofibrosarcoma

NCT01236144 2014-06-11

AML18 Pilot

Cardiff University

Phase 1/2 Completed
113 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡